Leveraging biobank resources successfully as a commercial enterprise is a complex and challenging undertaking. In this exclusive interview Heli Salimen-Mankonen, Research Director, Auria Biobank, speaks to Andrea Charles from Pharma IQ, about driving sustainability in biobanking.
Pharma IQ: What does sustainability in biobanking mean to you?
H Salimen-Mankonen: The ageing population in Finland as well as globally is resulting in an increased health care expenditure for people i...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More